N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine

C78H87F10N25O8S4 — CID 158894789

About N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine

N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine (PubChem CID 158894789) has the molecular formula C78H87F10N25O8S4 and a molecular weight of 1820.97 g/mol. Its IUPAC name is N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine.

Molecular Properties

• Compound Name: N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine
• PubChem CID: 158894789
• Molecular Formula: C78H87F10N25O8S4
• Molecular Weight: 1820.97 g/mol
• Exact Mass: 1819.59
• IUPAC Name: N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine
• SMILES: CS(=O)(=O)N1CC2(CCCN(c3cncc(-c4cnc5ccc(C(F)F)nn45)c3)C2)C1.CS(=O)(=O)NC1CCC2(CCN(c3cc(-c4cnc5ccc(C(F)F)nn45)ncn3)C2)C1.CS(=O)(=O)NCC1CN(c2ccnc(-c3cnc4ccc(C(F)F)nn34)c2)CCC1(F)F.CS(C)(=O)=NC[C@@H]1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ccn2)CCO1
• InChI: InChI=1S/C20H23F2N7O2S.C20H22F2N6O2S.C19H20F4N6O2S.C19H22F2N6O2S/c1-32(30,31)27-13-4-5-20(9-13)6-7-28(11-20)18-8-15(24-12-25-18)16-10-23-17-3-2-14(19(21)22)26-29(16)17;1-31(29,30)27-12-20(13-27)5-2-6-26(11-20)15-7-14(8-23-9-15)17-10-24-18-4-3-16(19(21)22)25-28(17)18;1-32(30,31)26-9-12-11-28(7-5-19(12,22)23)13-4-6-24-15(8-13)16-10-25-17-3-2-14(18(20)21)27-29(16)17;1-30(2,28)24-10-14-12-26(7-8-29-14)18-9-13(5-6-22-18)16-11-23-17-4-3-15(19(20)21)25-27(16)17/h2-3,8,10,12-13,19,27H,4-7,9,11H2,1H3;3-4,7-10,19H,2,5-6,11-13H2,1H3;2-4,6,8,10,12,18,26H,5,7,9,11H2,1H3;3-6,9,11,14,19H,7-8,10,12H2,1-2H3/t;;;14-/m...1/s1
• InChIKey: JERWDWSHPWAAHX-YSXYOLOCSA-N
• XLogP: 10.41
• TPSA: 366.55 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 30
• Rotatable Bonds: 20
• Heavy Atoms: 125
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1820.97
LogP ≤ 5	10.41
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	30

Frequently Asked Questions

What is the IUPAC name of N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine?

The IUPAC name of N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine (CID 158894789) is N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine.

What is the SMILES notation for N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine?

The canonical SMILES for N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine is CS(=O)(=O)N1CC2(CCCN(c3cncc(-c4cnc5ccc(C(F)F)nn45)c3)C2)C1.CS(=O)(=O)NC1CCC2(CCN(c3cc(-c4cnc5ccc(C(F)F)nn45)ncn3)C2)C1.CS(=O)(=O)NCC1CN(c2ccnc(-c3cnc4ccc(C(F)F)nn34)c2)CCC1(F)F.CS(C)(=O)=NC[C@@H]1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ccn2)CCO1.

What is the InChIKey of N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine?

The InChIKey is JERWDWSHPWAAHX-YSXYOLOCSA-N. The full InChI is InChI=1S/C20H23F2N7O2S.C20H22F2N6O2S.C19H20F4N6O2S.C19H22F2N6O2S/c1-32(30,31)27-13-4-5-20(9-13)6-7-28(11-20)18-8-15(24-12-25-18)16-10-23-17-3-2-14(19(21)22)26-29(16)17;1-31(29,30)27-12-20(13-27)5-2-6-26(11-20)15-7-14(8-23-9-15)17-10-24-18-4-3-16(19(21)22)25-28(17)18;1-32(30,31)26-9-12-11-28(7-5-19(12,22)23)13-4-6-24-15(8-13)16-10-25-17-3-2-14(18(20)21)27-29(16)17;1-30(2,28)24-10-14-12-26(7-8-29-14)18-9-13(5-6-22-18)16-11-23-17-4-3-15(19(20)21)25-27(16)17/h2-3,8,10,12-13,19,27H,4-7,9,11H2,1H3;3-4,7-10,19H,2,5-6,11-13H2,1H3;2-4,6,8,10,12,18,26H,5,7,9,11H2,1H3;3-6,9,11,14,19H,7-8,10,12H2,1-2H3/t;;;14-/m...1/s1.

What are the key properties of N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine?

N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine has a molecular weight of 1820.97 g/mol, XLogP of 10.41, 20 rotatable bonds, 2 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[1-[2-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-4-pyridinyl]-4,4-difluoropiperidin-3-yl]methyl]methanesulfonamide;[(2S)-4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methylimino-dimethyl-oxo-λ6-sulfane;N-[2-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-2-azaspiro[4.4]nonan-8-yl]methanesulfonamide;6-(difluoromethyl)-3-[5-(2-methylsulfonyl-2,8-diazaspiro[3.5]nonan-8-yl)-3-pyridinyl]imidazo[1,2-b]pyridazine is sourced from PubChem (CID 158894789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).